Meeting Report - (2012) Volume 3, Issue 3

Challenges Faced in the Integration of Pharmacogenetics/Genomics into Drug Development

Maliepaard Marc12, Flamion Bruno22, Vonderscher Jacky21, Tsouderos Yannis20, Rizzoli René19, Reginster Jean-Yves18, Pirmohamed Munir17, Paulmichel Markus16, Mitlak Bruce15, Meyer Joanne14, McHale Duncan13, Brandi Maria Luisa1*, Laurie David11, Laslop Andrea10, Kaufman Jean-Marc9, Ingelman-Sundberg Magnus8, Gouze Jean-Noel7, Goel Niti6, Ethgen Dominique5, Dere Willard4, Daly Ann3 and Abadie Eric2
1Department of Internal Medicine, University of Florence, Florence, Italy, E-mail: eric.abadie@gmail.com
2Direction Générale, Afssaps 143, 147, Bld Anatole, Saint Denis, France, E-mail: eric.abadie@gmail.com
3Newcastle University Medical School, Framlington Place, Newcastle upon Tyne NE24HH, UK, E-mail: eric.abadie@gmail.com
4Amgen Limited, 1 Uxbridge, UK Business Part, Sanderson Road, UB8 1DH, UK, E-mail: eric.abadie@gmail.com
5Medimmune, One Medimmune Way Gaithersburg, MD 20878, USA, E-mail: eric.abadie@gmail.com
6UCB 1950 Lake Park Drive Smyrna, GA 30080, USA, E-mail: eric.abadie@gmail.com
7Laboratoires Genevrier s.a., 280, Rue de GOA, Z.I. Les Trois Moulins 06600 Antibes, France, E-mail: eric.abadie@gmail.com
8Karolinska Institute of environmental Medecine, SE-171 77 Stockholm Nobels väg 5, Solna, Sweden, E-mail: eric.abadie@gmail.com
9Ghent University Hospital-De Pintelaan 185 B-9000 Gent, Belgium, E-mail: eric.abadie@gmail.com
10AGES PharmMed, Institute for Science and Information, Schnirchgasse 9, 1030 Vienna, Austria, E-mail: eric.abadie@gmail.com
11Novartis Pharma AG, Regulatory Affairs, Novartis Campus, St Johann, 4002 Basel, Switzerland, E-mail: eric.abadie@gmail.com
12Dutch Medicines Agency, 579 CBG/MEB - University Medical Centre St Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands, E-mail: eric.abadie@gmail.com
13ASTRAZENECA-Translational Sciences - DECS Mereside, 8F29, Alderley Park, SK10 4TG Macclesfield - Cheshire, UK, E-mail: eric.abadie@gmail.com
14Novartis Institutes for BioMedical Research - BioMarker Development, 220 Massachussets Ave- 02139 Cambridge – MA, USA, E-mail: eric.abadie@gmail.com
15Eli Lilly & Co, Lilly corporate center, D.C. 6134, Indianapolis, IN 46285, USA, E-mail: eric.abadie@gmail.com
16Paracelsus Medical University, Pharmacology and toxicology, Strubergasse 21, 5020 Salzburg, Austria, E-mail: eric.abadie@gmail.com
17University of Liverpool - Pharmacology, Sherrington Building Ashton Street - L69 3GE – Liverpool, UK, E-mail: eric.abadie@gmail.com
18CHU Centre Ville, 45 Quai Godefroid Kurth, 4020 Liege, Belgium, E-mail: eric.abadie@gmail.com
19University Hospital Bone Diseases Division, 1211 Geneva, Switzerland, E-mail: eric.abadie@gmail.com
20Institutions de Recherches Internationales SERVIER, 6, Place des Pléïades, 92400 Courbevoie, France, E-mail: eric.abadie@gmail.com
21F.Hoffmann - La Roche LTD Global Molecular Medecine LABS-PDL, Grenzacherstr 124, 4070 Basel, Switzerland, E-mail: eric.abadie@gmail.com
22University of Namur FUNDP, Department Phisiology and Pharmacology, 61 rue de Bruxelles, 5000 Namur, Belgium, E-mail: eric.abadie@gmail.com
*Corresponding Author: